Open AccessComparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in In vitro fertilisation cycles
Author(s) -
Maureen Uche Umemmuo,
ER Efetie,
Chris O. Agboghoroma,
J.A.F. Momoh,
Joseph Ifeanyichukwu Ikechebelu
Publication year - 2020
Publication title -
nigerian postgraduate medical journal
Language(s) - English
Resource type - Journals
ISSN - 1117-1936
DOI - 10.4103/npmj.npmj_65_20
Subject(s) - buserelin , goserelin , medicine , in vitro fertilisation , agonist , menotropins , hormone , gynecology , pregnancy , ovulation induction , biology , ovulation , receptor , cancer , breast cancer , genetics
Gonadotrophin-Releasing Hormone agonist (GnRHa) - long and short acting - is used for pituitary down regulation prior to ovarian stimulation in in vitro fertilisation (IVF) treatment. However, there are controversies in the literature as to their effectiveness, dose of gonadotrophin needed subsequently for ovarian stimulation and the clinical outcome.